Navigate to
-
Please enter a valid video URL. The URL can point to any video file or a Youtube video. Please enter a valid video URL. The URL can point to any video file or a Youtube video. Reimagine a PBM with...
-
April 14, 2025 Author: Simone Ndujiuba, PharmD, BCOP In the United States, pancreatic cancer is the fourth leading cause of cancer related death.¹ In 2023, approximately 64,050 people were...
-
References Sadelain M. Engineering the future – innovation in CAR T therapy design. Presented at Precision Medicine World Conference. March 4, 2026: Santa Clara, CA. Harris E, June C, Sadelain M....
-
Clinical Solutions Vice President (Remote) Job description: The Medicare Part D pharmacy programs manager manages the coordination of benefits in the pharmacy program with Medicare Part D plans,...
-
Prime Therapeutics’ newest Clinical Insights explores emerging evidence and innovations influencing treatment strategies and shaping healthcare decision-making
Prime Article: Stories -
High Cost Therapy Profile Eyebrow High-Cost Therapy Profile: February Detailed information about Marnetegragene autotemcel Intravenous (IV) Gene Therapy/Immunology Marnetegragene autotemcel...
-
NCCN Recommendations for use of immunoglobulin² Intervention CAR T BsAbs Other indications Immunoglobulin replacement After CAR T-cell therapy, regular immune globulin infusions based on clinical...
-
Integrated support for patients with cystic fibrosis drives down cost, improves medication adherence
Prime’s IntegratedRx® – Cystic Fibrosis product earns 94% member satisfaction rate
Prime Article: Stories